Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Aventis describes cyclic urea-based inhibitors of IGF-1R and other kinases

Sep. 20, 2004

Three series of Src kinase inhibitors presented by AstraZeneca

Sep. 20, 2004

Alfacell licenses antibody from NIH

Sep. 20, 2004

Ziopharm licenses new class of organic arsenicals from M.D. Anderson

Sep. 17, 2004

Antigen Express collaborates on melanoma vaccine development

Sep. 17, 2004

CA4P investigated in combination with cisplatin in phase I cervical cancer study

Sep. 17, 2004

Gliadel approved for new indication in Europe

Sep. 17, 2004

Pivotal trial of NovaCaps given green light by EMEA

Sep. 16, 2004

SPA for phase III study of glufosfamide for metastatic pancreatic cancer

Sep. 15, 2004

Iressa studied in new head-to-head trial for NSCLC

Sep. 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...